Quantcast
Last updated on April 19, 2014 at 9:20 EDT

Latest Connective tissue diseases Stories

2011-10-12 10:35:00

PORTLAND, Ore., Oct. 12, 2011 /PRNewswire-USNewswire/ -- If you have psoriasis or a family history of psoriasis and you are experiencing joint pain and swelling, you could have psoriatic arthritis, a serious disease that may lead to joint destruction and disability. New research from the National Psoriasis Foundation reveals that nearly one in four people with psoriasis--the most common autoimmune disease in the country, affecting as many as 7.5 million Americans--may have undiagnosed...

2011-10-11 10:27:00

NEW YORK, Oct. 11, 2011 /PRNewswire-USNewswire/ -- The following release is being issued by the Arthritis Foundation: (Photo: http://photos.prnewswire.com/prnh/20111011/DC83806) What: The Empire State Building, in partnership with the Arthritis Foundation, will be illuminated in blue on the evening of October 12 to commemorate World Arthritis Day and honor the 50 million Americans who have arthritis, the nation's leading cause of disability. When: Wednesday, October 12, 2011, at...

2011-10-04 07:00:00

Raising Awareness for Lupus Science and Services in New York and the Nation (PRWEB) October 04, 2011 The S.L.E. Lupus Foundation opened a window on the world of lupus, unveiling a 115-square foot display window yesterday at 10 Rockefeller Plaza, to generate awareness for lupus, a dangerous autoimmune disease that primarily affects young women. The window also brings a message of hope to those already diagnosed, offering help from the S.L.E. Lupus Foundation in the form of services to...

2011-10-04 11:10:00

Educational Conference Helps Young Adults with Arthritis, the Leading Cause of Disability in the United States LOS ANGELES, Oct. 4, 2011 /PRNewswire-USNewswire/ -- The Arthritis Foundation is sponsoring the 2nd Annual Arthritis in PrimeTime symposium on Saturday, October 22 at the Long Beach Renaissance Hotel in Long Beach. This premier educational and motivational event fosters active and fulfilling lives for young adults (ages 17-45 years old) affected by arthritis, fibromyalgia,...

2011-10-04 10:15:00

To view the Social Media Release, click here: http://smr.newswire.ca/en/lupus-canada/october-is-lupus-awareness-month MARKHAM, ON, Oct. 4, 2011 /PRNewswire/ - The first new treatment in 50 years has brought increased awareness across Canada of lupus and its impact on patients and their families. This is great news for Lupus Canada and its provincial partners as we work towards a vision of life without lupus. Known as 'The Disease with 1000 Faces", lupus affects tens of...

2011-09-30 14:24:00

WASHINGTON, Sept. 30, 2011 /PRNewswire/ -- Purple passion will cap a month of pink ribbons--raising funds and awareness for people with lupus, a still-unknown disease. More than 1,000 people with lupus, their families, friends and co-workers dressed in purple will carry butterflies in the Third Annual Walk for Lupus Now! Richmond on Saturday, Oct. 29 at 3:00 p.m. Affecting mostly women, lupus is a chronic, autoimmune disease with no known cure that can damage any part of the body...

2011-09-28 08:20:01

Tokyo, Sept 28, 2011 - (JCN Newswire) - Abbott Japan Co., Ltd. and Eisai Co., Ltd. announced today that they will launch Humira(R) (adalimumab) Prefilled Syringe 20mg/0.4mL, a fully human anti-TNF-α monoclonal antibody for the treatment of polyarticular juvenile idiopathic arthritis (JIA) patients with low body weight, on September 29.Humira Prefilled Syringe 20mg/0.4mL received manufacturing and marketing approval from Japan's Ministry of Health, Labour and Welfare on July 1 of this...

2011-09-26 14:33:00

ROCKVILLE, Md., Sept. 26, 2011 /PRNewswire-USNewswire/ -- Medications known as disease-modifying anti-rheumatic drugs, or DMARDs, appear to be more effective than other treatments for children with arthritis, but there is not enough evidence to support one kind of DMARD over another, according to a new report from HHS' Agency for Healthcare Research and Quality (AHRQ). The report compared DMARDs with conventional treatments such as ibuprofen and steroids. It found that DMARDs are more...

2011-09-26 04:20:01

Tokyo, Sept 26, 2011 - (JCN Newswire) - Abbott Japan Co., Ltd. and Eisai Co., Ltd. announced today that they have submitted an application in Japan seeking approval of inhibition of structural damage of joints in rheumatoid arthritis as an additional indication for Humira(R) (adalimumab; recombinant) Pre-filled Syringe 40 mg/0.8 mL, a fully human anti-TNF-alpha monoclonal antibody jointly developed by the two companies.The submission is based on the results of a double-blind study (HOPEFUL1...

2011-09-23 09:00:00

Funding Aims to Improve Lupus Detection Nationwide New York, NY (PRWEB) September 23, 2011 The S.L.E. Lupus Foundation and Lupus Research Institute (LRI) commend the entire U.S. Senate Appropriations Committee for recognizing the urgent need for greater health education in lupus with the adoption of its fiscal 2012 Labor, Health and Human Services and Education appropriations bill September 21. The Senate legislation allocates $1 million to continue the current federal lupus education...